Sidoti Upgrades InfuSystem (NYSE:INFU) to Strong-Buy

InfuSystem (NYSE:INFU) was upgraded by research analysts at Sidoti to a “strong-buy” rating in a report released on Tuesday,Zacks.com reports.

Separately, StockNews.com upgraded InfuSystem from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 14th.

InfuSystem Price Performance

NYSE:INFU opened at $5.72 on Tuesday. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $120.17 million, a P/E ratio of 95.35 and a beta of 1.75. InfuSystem has a 12 month low of $5.29 and a 12 month high of $9.97. The business’s 50-day moving average is $7.51 and its 200 day moving average is $7.55.

Institutional Investors Weigh In On InfuSystem

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. First Eagle Investment Management LLC raised its position in InfuSystem by 25.9% during the fourth quarter. First Eagle Investment Management LLC now owns 908,371 shares of the company’s stock valued at $7,676,000 after purchasing an additional 186,668 shares during the period. Meros Investment Management LP grew its stake in shares of InfuSystem by 2.6% during the fourth quarter. Meros Investment Management LP now owns 631,105 shares of the company’s stock valued at $5,333,000 after buying an additional 16,178 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of InfuSystem by 5.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 456,043 shares of the company’s stock valued at $3,853,000 after buying an additional 21,697 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of InfuSystem by 1.8% during the fourth quarter. Geode Capital Management LLC now owns 444,476 shares of the company’s stock valued at $3,756,000 after buying an additional 7,968 shares during the last quarter. Finally, Renaissance Technologies LLC grew its stake in shares of InfuSystem by 2.6% during the fourth quarter. Renaissance Technologies LLC now owns 337,609 shares of the company’s stock valued at $2,853,000 after buying an additional 8,700 shares during the last quarter. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.